Use of (1→3)-β-d-glucan for diagnosis and management of invasive mycoses in HIV-infected patients.
Review findings on the merits of (1→3)‐β‐d‐glucan (BDG) assays in the diagnosis of invasive fungal infections (IFIs) and monitoring of antifungal therapies for people living with HIV
View Publication